Literature DB >> 9230131

Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera.

J D Rowe1, E Nieves, I Listowsky.   

Abstract

Uncertainties about the composition and identities of glutathione S-transferases (GSTs) in human tissue have impeded studies on their biological functions. A rigorous protocol has therefore been developed to characterize the human proteins. Cytosolic GST subunits were resolved by reverse-phase HPLC methods, individual components were assigned to Alpha, Mu and Pi classes on the basis of their immunoreactivities, and peptide-sequence-specific antisera were used to distinguish among five different Mu-class subunits (GSTM1-GSTM5). Each subunit type was characterized and identified unambiguously by electrospray ionization-MS. Acetylation of N-terminal residues in the GSTA1, GSTA2, GSTM3 and GSTM4 subunits were the only natural post-translational modifications detected. The unique structure of GSTM3, with N- and C-terminal peptide extensions predicted from cDNA sequences, was confirmed. Only testis and brain were rich sources of GSTM3 subunits. Subunit profiles were distinct and characteristic of the particular tissue type, and this tissue specificity in GST expression was evident even in organs from different individuals. For instance, livers had relatively simple GST compositions, consisting of a preponderance of Alpha-class subunits and GSTM1 (when present). By contrast, representation of most subunit types was a characteristic feature of testis, which had the highest levels of GSTs. GSTM4 and GSTM5 subunits, here identified for the first time in human tissue extracts, were minor components, with GSTM5 found only in brain, lung and testis. Specimens devoid of GSTM1 subunits, particularly those from null-genotype individuals, were readily discerned at the protein level. Liver was the only rich source of the GSTM1 subunit (although it also constituted a major fraction of adrenal GSTs), and so the functional consequences of the GSTM1 gene deletion are likely to vary in extrahepatic tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230131      PMCID: PMC1218585          DOI: 10.1042/bj3250481

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

Review 1.  The enzymes of detoxication.

Authors:  W B Jakoby; D M Ziegler
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

2.  Structure of the human genomic glutathione S-transferase-pi gene.

Authors:  C S Morrow; K H Cowan; M E Goldsmith
Journal:  Gene       Date:  1989-01-30       Impact factor: 3.688

3.  Evidence that glutathione S-transferases B1B1 and B2B2 are the products of separate genes and that their expression in human liver is subject to inter-individual variation. Molecular relationships between the B1 and B2 subunits and other Alpha class glutathione S-transferases.

Authors:  J D Hayes; L A Kerr; A D Cronshaw
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

Review 4.  Intracellular binding and transport of hormones and xenobiotics by glutathione-S-transferases.

Authors:  I Listowsky; M Abramovitz; H Homma; Y Niitsu
Journal:  Drug Metab Rev       Date:  1988       Impact factor: 4.518

5.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Authors:  J Seidegård; W R Vorachek; R W Pero; W R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 6.  Glutathione transferases--structure and catalytic activity.

Authors:  B Mannervik; U H Danielson
Journal:  CRC Crit Rev Biochem       Date:  1988

Review 7.  Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress.

Authors:  J D Hayes; R C Strange
Journal:  Free Radic Res       Date:  1995-03

8.  A distinct human testis and brain mu-class glutathione S-transferase. Molecular cloning and characterization of a form present even in individuals lacking hepatic type mu isoenzymes.

Authors:  E Campbell; Y Takahashi; M Abramovitz; M Peretz; I Listowsky
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

9.  Glutathione S-transferase is an in vitro substrate of Ca++-phospholipid-dependent protein kinase (protein kinase C).

Authors:  H Taniguchi; W Pyerin
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

10.  Variation in the expression of Mu-class glutathione S-transferase isoenzymes from human skeletal muscle. Evidence for the existence of heterodimers.

Authors:  A J Hussey; L A Kerr; A D Cronshaw; D J Harrison; J D Hayes
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

View more
  38 in total

1.  Secretion of glutathione S-transferase isoforms in the seminiferous tubular fluid, tissue distribution and sex steroid binding by rat GSTM1.

Authors:  S B Mukherjee; S Aravinda; B Gopalakrishnan; S Nagpal; D M Salunke; C Shaha
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients.

Authors:  Nasir Ali Afsar; Mike Ufer; Sierk Haenisch; Cornelia Remmler; Ahmed Mateen; Ahmed Usman; Khwaja Zafar Ahmed; Hakimuddin Razi Ahmad; Ingolf Cascorbi
Journal:  Eur J Clin Pharmacol       Date:  2011-10-20       Impact factor: 2.953

3.  Molecular complex of three testis-specific isozymes associated with the mouse sperm fibrous sheath: hexokinase 1, phosphofructokinase M, and glutathione S-transferase mu class 5.

Authors:  Noriko Nakamura; Chisato Mori; Edward M Eddy
Journal:  Biol Reprod       Date:  2009-11-04       Impact factor: 4.285

4.  Evidence that human class Theta glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GST T1-1 with that of classes Alpha, Mu and Pi GST in human.

Authors:  P J Sherratt; D J Pulford; D J Harrison; T Green; J D Hayes
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

5.  Genetic polymorphisms of GSTT1, GSTM1, GSTP1, MnSOD, and catalase in nonhereditary chronic pancreatitis: evidence of xenobiotic stress and impaired antioxidant capacity.

Authors:  Sakhawat Hussain Rahman; Chaddha Nanny; Khadija Ibrahim; Derek O'Reilly; Michael Larvin; Andrew J Kingsnorth; Michael J McMahon
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

6.  The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Authors:  Adrienne Tin; Robert Scharpf; Michelle M Estrella; Bing Yu; Megan L Grove; Patricia P Chang; Kunihiro Matsushita; Anna Köttgen; Dan E Arking; Eric Boerwinkle; Thu H Le; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121

7.  Reciprocal regulation of glutathione S-transferase spliceforms and the Drosophila c-Jun N-terminal kinase pathway components.

Authors:  Rungrutai Udomsinprasert; Marie A Bogoyevitch; Albert J Ketterman
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

8.  CYP2D6, GST-M1 and GST-T1 enzymes: expression in parathyroid gland and association with the parathyroid hormone concentration during early renal replacement therapy.

Authors:  Feng-Xiang Yan; M Chris Langub; Mark A Ihnen; Carlton Hornung; Erkki Juronen; Mary K Rayens; Wei-Min Cai; Peter J Wedlund; Paolo Fanti
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

9.  Structure-Based Design of Anticancer Prodrug PABA/NO.

Authors:  Xinhua Ji; Ajai Pal; Ravi Kalathur; Xun Hu; Yijun Gu; Joseph E Saavedra; Gregory S Buzard; Aloka Srinivasan; Larry K Keefer; Shivendra V Singh
Journal:  Drug Des Devel Ther       Date:  2008       Impact factor: 4.162

10.  The 341C/T polymorphism in the GSTP1 gene is associated with increased risk of oesophageal cancer.

Authors:  Dongping Li; Collet Dandara; M Iqbal Parker
Journal:  BMC Genet       Date:  2010-06-11       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.